{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:56:47Z","timestamp":1793307407128,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL142251"],"award-info":[{"award-number":["HL142251"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL162369"],"award-info":[{"award-number":["HL162369"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL121754"],"award-info":[{"award-number":["HL121754"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"LEXEO Therapeutics Inc."},{"name":"Additional Ventures, Joe and Clara Tsai Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a fatal genetic heart disease characterized by cardiac arrhythmias, in which fibrofatty deposition leads to heart failure, with no effective treatments. Plakophilin\u20092 (\n                    <jats:italic>PKP2<\/jats:italic>\n                    ) is the most frequently mutated gene in ARVC, and although altered RNA splicing has been implicated, there are no models to study its effect and therapeutics. Here, we generate a mouse model harboring a\n                    <jats:italic>PKP2<\/jats:italic>\n                    mutation (IVS10-1G&gt;C) affecting RNA splicing, recapitulating ARVC features and sudden death starting at 4\u2009weeks. Administering AAV-PKP2 gene therapy (adeno-associated viral therapy to drive cardiac expression of\n                    <jats:italic>PKP2<\/jats:italic>\n                    ) to neonatal mice restored PKP2 protein levels, completely preventing cardiac desmosomal and pathological deficits associated with ARVC, ensuring 100% survival of mice up to 6\u2009months. Late-stage AAV-PKP2 administration rescued desmosomal protein deficits and reduced pathological deficits including improved cardiac function in adult mice, resulting in 100% survival up to 4\u2009months. We suggest that AAV-PKP2 gene therapy holds promise for circumventing ARVC associated with\n                    <jats:italic>PKP2<\/jats:italic>\n                    mutations, including splice\u2009site mutations.\n                  <\/jats:p>","DOI":"10.1038\/s44161-023-00370-3","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T06:04:35Z","timestamp":1701929075000},"page":"1246-1261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Plakophilin\u20092 gene therapy prevents and rescues arrhythmogenic right ventricular cardiomyopathy in a mouse model harboring patient genetics"],"prefix":"10.1038","volume":"2","author":[{"given":"William H.","family":"Bradford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika J.","family":"Gutierrez-Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryanne","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsui-Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirosh","family":"Mataraarachchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McCulloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk L.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2610-0125","authenticated-orcid":false,"given":"Farah","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"370_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-45","volume":"2","author":"G Thiene","year":"2007","unstructured":"Thiene, G., Corrado, D. & Basso, C. Arrhythmogenic right ventricular cardiomyopathy\/dysplasia. Orphanet J. Rare Dis. 2, 45 (2007).","journal-title":"Orphanet J. Rare Dis."},{"key":"370_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev.med.052208.130419","volume":"61","author":"S Sen-Chowdhry","year":"2010","unstructured":"Sen-Chowdhry, S. et al. Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. Annu. Rev. Med. 61, 233\u2013253 (2010).","journal-title":"Annu. Rev. Med."},{"key":"370_CR3","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/jcm9030878","volume":"9","author":"G Mattesi","year":"2020","unstructured":"Mattesi, G. et al. Natural history of arrhythmogenic cardiomyopathy. J. Clin. Med. 9, 878 (2020).","journal-title":"J. Clin. Med."},{"key":"370_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ijcard.2003.10.037","volume":"97","author":"S Peters","year":"2004","unstructured":"Peters, S., Trummel, M. & Meyners, W. Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital. Int. J. Cardiol. 97, 499\u2013501 (2004).","journal-title":"Int. J. Cardiol."},{"key":"370_CR5","first-page":"91","volume":"112","author":"J Elias Neto","year":"2019","unstructured":"Elias Neto, J. et al. Arrhythmogenic right ventricular cardiomyopathy\/dysplasia (ARVC\/D) - what we have learned after 40 years of the diagnosis of this clinical entity. Arq. Bras. Cardiol. 112, 91\u2013103 (2019).","journal-title":"Arq. Bras. Cardiol."},{"key":"370_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/20009666.2018.1472513","volume":"8","author":"A Idris","year":"2018","unstructured":"Idris, A., Shah, S. R. & Park, K. Right ventricular dysplasia: management and treatment in light of current evidence. J. Community Hosp. Intern. Med. Perspect. 8, 101\u2013106 (2018).","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"370_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/europace\/euy063","volume":"21","author":"W Wang","year":"2019","unstructured":"Wang, W., James, C. A. & Calkins, H. Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia\/cardiomyopathy patient. Europace 21, 9\u201321 (2019).","journal-title":"Europace"},{"key":"370_CR8","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jacc.2013.01.073","volume":"61","author":"FI Marcus","year":"2013","unstructured":"Marcus, F. I., Edson, S. & Towbin, J. A. Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. J. Am. Coll. Cardiol. 61, 1945\u20131948 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"370_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.tcm.2009.12.001","volume":"19","author":"F Sheikh","year":"2009","unstructured":"Sheikh, F., Ross, R. S. & Chen, J. Cell-cell connection to cardiac disease. Trends Cardiovasc. Med. 19, 182\u2013190 (2009).","journal-title":"Trends Cardiovasc. Med."},{"key":"370_CR10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/CIRCGENETICS.114.000645","volume":"7","author":"A Rampazzo","year":"2014","unstructured":"Rampazzo, A. et al. Intercalated discs and arrhythmogenic cardiomyopathy. Circ. Cardiovasc. Genet. 7, 930\u2013940 (2014).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"370_CR11","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/ng1461","volume":"36","author":"B Gerull","year":"2004","unstructured":"Gerull, B. et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat. Genet. 36, 1162\u20131164 (2004).","journal-title":"Nat. Genet."},{"key":"370_CR12","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCGENETICS.111.961854","volume":"5","author":"F Kirchner","year":"2012","unstructured":"Kirchner, F. et al. Molecular insights into arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 missense mutations. Circ. Cardiovasc. Genet. 5, 400\u2013411 (2012).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"370_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCGENETICS.113.000338","volume":"7","author":"TB Rasmussen","year":"2014","unstructured":"Rasmussen, T. B. et al. Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermis. Circ. Cardiovasc. Genet. 7, 230\u2013240 (2014).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"370_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.hrthm.2015.11.010","volume":"13","author":"D Akdis","year":"2016","unstructured":"Akdis, D. et al. Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia compared to those with dilated cardiomyopathy and healthy controls. Heart Rhythm 13, 731\u2013741 (2016).","journal-title":"Heart Rhythm"},{"key":"370_CR15","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.hrthm.2014.07.041","volume":"11","author":"JA Groeneweg","year":"2014","unstructured":"Groeneweg, J. A. et al. Functional assessment of potential splice site variants in arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Heart Rhythm 11, 2010\u20132017 (2014).","journal-title":"Heart Rhythm"},{"key":"370_CR16","doi-asserted-by":"publisher","first-page":"11093","DOI":"10.1073\/pnas.1101135108","volume":"108","author":"KH Lim","year":"2011","unstructured":"Lim, K. H. et al. Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes. Proc. Natl Acad. Sci. USA 108, 11093\u201311098 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"370_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13353-018-0444-7","volume":"59","author":"A Anna","year":"2018","unstructured":"Anna, A. & Monika, G. Splicing mutations in human genetic disorders: examples, detection, and confirmation. J. Appl. Genet. 59, 253\u2013268 (2018).","journal-title":"J. Appl. Genet."},{"key":"370_CR18","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1093\/hmg\/ddp290","volume":"18","author":"R Attali","year":"2009","unstructured":"Attali, R. et al. Mutation of SYNE-1, encoding an essential component of the nuclear lamina, is responsible for autosomal recessive arthrogryposis. Hum. Mol. Genet. 18, 3462\u20133469 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"370_CR19","doi-asserted-by":"publisher","first-page":"e1001081","DOI":"10.1371\/journal.pgen.1001081","volume":"6","author":"DL Guernsey","year":"2010","unstructured":"Guernsey, D. L. et al. Mutation in the gene encoding ubiquitin ligase LRSAM1 in patients with Charcot-Marie-Tooth disease. PLoS Genet. 6, e1001081 (2010).","journal-title":"PLoS Genet."},{"key":"370_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2169\/internalmedicine.52.9213","volume":"52","author":"T Watanabe","year":"2013","unstructured":"Watanabe, T. et al. A mutant mRNA expression in an endomyocardial biopsy sample obtained from a patient with a cardiac variant of Fabry disease caused by a novel acceptor splice site mutation in the invariant AG of intron 5 of the alpha-galactosidase A gene. Intern. Med. 52, 777\u2013780 (2013).","journal-title":"Intern. Med."},{"key":"370_CR21","first-page":"55","volume":"6","author":"A Svensson","year":"2016","unstructured":"Svensson, A. et al. Arrhythmogenic right ventricular cardiomyopathy - 4 Swedish families with an associated PKP2 c.2146-1G>C variant. Am. J. Cardiovasc. Dis. 6, 55\u201365 (2016).","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"370_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/CIRCULATIONAHA.105.561654","volume":"113","author":"P Syrris","year":"2006","unstructured":"Syrris, P. et al. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy. Circulation 113, 356\u2013364 (2006).","journal-title":"Circulation"},{"key":"370_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/gim.2016.90","volume":"19","author":"R Walsh","year":"2017","unstructured":"Walsh, R. et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet. Med. 19, 192\u2013203 (2017).","journal-title":"Genet. Med."},{"key":"370_CR24","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/hmg\/ddt508","volume":"23","author":"RC Lyon","year":"2014","unstructured":"Lyon, R. C. et al. Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model. Hum. Mol. Genet. 23, 1134\u20131150 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"370_CR25","first-page":"1313","volume":"31","author":"A Asimaki","year":"2015","unstructured":"Asimaki, A., Kleber, A. G. & Saffitz, J. E. Pathogenesis of arrhythmogenic cardiomyopathy. Can. J. Cardiol. 31, 1313\u20131324 (2015).","journal-title":"Can. J. Cardiol."},{"key":"370_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.tcm.2014.02.001","volume":"24","author":"M Cerrone","year":"2014","unstructured":"Cerrone, M. & Delmar, M. Desmosomes and the sodium channel complex: implications for arrhythmogenic cardiomyopathy and Brugada syndrome. Trends Cardiovasc. Med. 24, 184\u2013190 (2014).","journal-title":"Trends Cardiovasc. Med."},{"key":"370_CR27","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1093\/eurheartj\/ehl095","volume":"27","author":"C Basso","year":"2006","unstructured":"Basso, C. et al. Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. Eur. Heart J. 27, 1847\u20131854 (2006).","journal-title":"Eur. Heart J."},{"key":"370_CR28","doi-asserted-by":"publisher","first-page":"e137689","DOI":"10.1172\/JCI137689","volume":"131","author":"Y Liang","year":"2021","unstructured":"Liang, Y. et al. Desmosomal COP9 regulates proteome degradation in arrhythmogenic right ventricular dysplasia\/cardiomyopathy. J. Clin. Invest. 131, e137689 (2021).","journal-title":"J. Clin. Invest."},{"key":"370_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.carpath.2004.12.001","volume":"14","author":"C Basso","year":"2005","unstructured":"Basso, C. & Thiene, G. Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat?. Cardiovasc. Pathol. 14, 37\u201341 (2005).","journal-title":"Cardiovasc. Pathol."},{"key":"370_CR30","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/jce.12222","volume":"24","author":"AS Te Riele","year":"2013","unstructured":"Te Riele, A. S. et al. Mutation-positive arrhythmogenic right ventricular dysplasia\/cardiomyopathy: the triangle of dysplasia displaced. J. Cardiovasc. Electrophysiol. 24, 1311\u20131320 (2013).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"370_CR31","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1161\/CIRCULATIONAHA.119.040676","volume":"140","author":"SP Chelko","year":"2019","unstructured":"Chelko, S. P. et al. Therapeutic modulation of the immune response in arrhythmogenic cardiomyopathy. Circulation 140, 1491\u20131505 (2019).","journal-title":"Circulation"},{"key":"370_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.118.038514","volume":"140","author":"VJ Bezzerides","year":"2019","unstructured":"Bezzerides, V. J. et al. Gene therapy for catecholaminergic polymorphic ventricular tachycardia by inhibition of Ca(2+)\/calmodulin-dependent kinase II. Circulation 140, 405\u2013419 (2019).","journal-title":"Circulation"},{"key":"370_CR33","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/ijms21041335","volume":"21","author":"JM Lambert","year":"2020","unstructured":"Lambert, J. M. et al. Mechanisms and regulation of nonsense-mediated mRNA decay and nonsense-associated altered splicing in lymphocytes. Int. J. Mol. Sci. 21, 1335 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"370_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1083\/jcb.200402096","volume":"167","author":"KS Grossmann","year":"2004","unstructured":"Grossmann, K. S. et al. Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. J. Cell Biol. 167, 149\u2013160 (2004).","journal-title":"J. Cell Biol."},{"key":"370_CR35","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/hmg\/ddw213","volume":"25","author":"J Moncayo-Arlandi","year":"2016","unstructured":"Moncayo-Arlandi, J. et al. Molecular disturbance underlies to arrhythmogenic cardiomyopathy induced by transgene content, age and exercise in a truncated PKP2 mouse model. Hum. Mol. Genet. 25, 3676\u20133688 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"370_CR36","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jacc.2015.01.045","volume":"65","author":"FM Cruz","year":"2015","unstructured":"Cruz, F. M. et al. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2. J. Am. Coll. Cardiol. 65, 1438\u20131450 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"370_CR37","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/S0140-6736(00)02379-5","volume":"355","author":"G McKoy","year":"2000","unstructured":"McKoy, G. et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355, 2119\u20132124 (2000).","journal-title":"Lancet"},{"key":"370_CR38","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1172\/JCI80335","volume":"125","author":"Z Zhang","year":"2015","unstructured":"Zhang, Z. et al. Normalization of Naxos plakoglobin levels restores cardiac function in mice. J. Clin. Invest. 125, 1708\u20131712 (2015).","journal-title":"J. Clin. Invest."},{"key":"370_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00127-0","volume":"8","author":"M Cerrone","year":"2017","unstructured":"Cerrone, M. et al. Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm. Nat. Commun. 8, 106 (2017).","journal-title":"Nat. Commun."},{"key":"370_CR40","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1161\/CIRCRESAHA.110.223412","volume":"107","author":"M Delmar","year":"2010","unstructured":"Delmar, M. & McKenna, W. J. The cardiac desmosome and arrhythmogenic cardiomyopathies: from gene to disease. Circ. Res. 107, 700\u2013714 (2010).","journal-title":"Circ. Res."},{"key":"370_CR41","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1161\/CIRCRESAHA.116.304937","volume":"116","author":"RC Lyon","year":"2015","unstructured":"Lyon, R. C. et al. Mechanotransduction in cardiac hypertrophy and failure. Circ. Res. 116, 1462\u20131476 (2015).","journal-title":"Circ. Res."},{"key":"370_CR42","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.1074\/jbc.M108765200","volume":"277","author":"X Chen","year":"2002","unstructured":"Chen, X. et al. Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta-catenin signaling. J. Biol. Chem. 277, 10512\u201310522 (2002).","journal-title":"J. Biol. Chem."},{"key":"370_CR43","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ceb.2009.07.002","volume":"21","author":"AE Bass-Zubek","year":"2009","unstructured":"Bass-Zubek, A. E. et al. Plakophilins: multifunctional scaffolds for adhesion and signaling. Curr. Opin. Cell Biol. 21, 708\u2013716 (2009).","journal-title":"Curr. Opin. Cell Biol."},{"key":"370_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/srep42244","volume":"7","author":"X Ma","year":"2017","unstructured":"Ma, X. et al. CRISPR\/Cas9-mediated gene manipulation to create single-amino-acid-substituted and floxed mice with a cloning-free method. Sci. Rep. 7, 42244 (2017).","journal-title":"Sci. Rep."},{"key":"370_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41591-019-0674-1","volume":"26","author":"M Bravo-Hernandez","year":"2020","unstructured":"Bravo-Hernandez, M. et al. Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS. Nat. Med. 26, 118\u2013130 (2020).","journal-title":"Nat. Med."},{"key":"370_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF02254434","volume":"11","author":"CE Chiang","year":"2004","unstructured":"Chiang, C. E., Wang, T. M. & Luk, H. N. Inhibition of L-type Ca2+ current in guinea pig ventricular myocytes by cisapride. J. Biomed. Sci. 11, 303\u2013314 (2004).","journal-title":"J. Biomed. Sci."},{"key":"370_CR47","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/CIRCRESAHA.109.201418","volume":"105","author":"PY Sato","year":"2009","unstructured":"Sato, P. Y. et al. Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ. Res. 105, 523\u2013526 (2009).","journal-title":"Circ. Res."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00370-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00370-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00370-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:20:05Z","timestamp":1788344405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00370-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1038\/s44161-023-00370-3","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,7]]},"assertion":[{"value":"23 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.S. was a co-founder of Stelios Therapeutics (acquired by LEXEO Therapeutics) and is a co-founder and shareholder of Papillon Therapeutics Inc as well as a consultant and shareholder of LEXEO Therapeutics Inc. A.M. is a co-founder of and equity holder in Insilicomed Inc and Vektor Medical Inc. For A.M., findings reported in this study did not involve the companies he is involved with in any way, and these findings have no relationship with the business activities or scientific interests of either company. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}